Suchergebnisse - "Daguenet, Elisabeth"

PubPharm (6)

1

Real-world therapeutic response and tyrosine kinase inhibitor discontinuation in chronic phase-chronic myeloid leukemia: data from the French observatory

enthalten in: Annals of hematology | 2022

von Saugues, S. | Lambert, C. | Daguenet, E. | +9

2

Performance evaluation of a new mobile air-treatment technology at-rest and under normal work conditions in a conventional hematology room

enthalten in: Health and technology | 2020

von Pouvaret, A. | Tavernier, E. | Cornillon, J. | +5

3

BAM conditioning before autologous transplantation for lymphoma: a study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

enthalten in: Annals of hematology | 2019

von Cornillon, J. | Daguenet, E. | Bay, J. | +16

4

L’épissage des ARN pré-messagers : quand le splicéosome perd pied

enthalten in: Médecine sciences | 2016

von Dujardin, G. | Daguenet, �. | Bernard, D. | +6

5

The pathogenicity of splicing defects: mechanistic insights into pre‐mRNA processing inform novel therapeutic approaches

enthalten in: EMBO reports | 2015

von Daguenet, E. | Dujardin, G. | Valcárcel, J.

6

EJC core component MLN51 interacts with eIF3 and activates translation

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2013

von Chazal, P. | Daguenet, E. | Wendling, C. | +4

1
[1]